Pfizer Begins Clinical Trial Of COVID-19 Antiviral Paxlovid In Kids
Newsy
The drug company announced Wednesday it has started a clinical trial for Paxlovid in kids ages 6 to 17.
Drugmaker Pfizer is now testing an antiviral pill to treat COVID in younger children.
The drug company announced Wednesday it has started a clinical trial for Paxlovid in kids ages 6 to 17.
The FDA has already authorized this treatment for high-risk individuals ages 12 and older.
More Related News